Loperamide potentiates doxorubicin sensitivity in triple‐negative breast cancer cells by targeting MDR1 and JNK and suppressing mTOR and Bcl‐2: In vitro and molecular docking study-Reference-Cited by-同舟云学术

Loperamide potentiates doxorubicin sensitivity in triple‐negative breast cancer cells by targeting MDR1 and JNK and suppressing mTOR and Bcl‐2: In vitro and molecular docking study

Published:2021-10-31 Issue:1 Volume:36 Page:
ISSN:1095-6670
Container-title:Journal of Biochemical and Molecular Toxicology
language:en
Short-container-title:J Biochem & Molecular Tox

Author:

Elia Shenouda G.¹^ORCID,Al‐Karmalawy Ahmed A.²^ORCID,Nasr Mohamed Y.¹^ORCID,Elshal Mohamed F.¹^ORCID

Affiliation:

1. Department of Molecular Biology, Genetic Engineering and Biotechnology Research Institute University of Sadat City Sadat City Egypt

2. Department of Pharmaceutical Medicinal Chemistry, Faculty of Pharmacy Horus University‐Egypt New Damietta Egypt

Publisher

Wiley

Subject

Health, Toxicology and Mutagenesis,Toxicology,Molecular Biology,Molecular Medicine,Biochemistry,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jbt.22938

Reference59 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Mammographic density and risk of breast cancer by age and tumor characteristics

3. World Cancer Report 2014. Geneva, Switzerland: World Health Organization, International Agency for Research on Cancer, WHO Press, 2015

4. A new gene expression signature, the ClinicoMolecular Triad Classification, may improve prediction and prognostication of breast cancer at the time of diagnosis

5. A Review of Triple-Negative Breast Cancer

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sitagliptin synergizes 5‐fluorouracil efficacy in colon cancer cells through MDR1‐mediated flux impairment and down regulation of NFκB2 and p‐AKT survival proteins;Journal of Biochemical and Molecular Toxicology;2024-08

2. Antiviral potential of rosuvastatin and hesperidin in combination with favipiravir liposomal nanoformulations in targeting the main protease (Mpro) of SARS-CoV-2: Molecular docking, molecular dynamics and in-vitro studies;Journal of Drug Delivery Science and Technology;2024-08

3. Repurposing of Loperamide as a New Drug With Anticancer Activity for Human Osteosarcoma;Anticancer Research;2024-02-29

4. Targeting EGFR and VEGFR-2 Kinases With Nanoparticles: A Computational Approach for Cancer Therapy Advancement;Cancer Investigation;2024-02-07

5. Emerging biomarkers and potential therapeutics of the BCL-2 protein family: the apoptotic and anti-apoptotic context;Egyptian Journal of Medical Human Genetics;2024-01-27